Structured Review

Kaneka Corp ox coq9
Imaging mass spectrometry (IMS) of CoQs. Optical image of a sagittal tissue section from the mouse brain ( a ) control and ( b ) Re-CoQ10-treated mouse). MS spectra reconstructed image of Re-CoQ10 ( c ) control and ( d ) Re-CoQ10-treated mouse, Ox-CoQ10 ( e ) control and ( f ) Re-CoQ10-treated mouse <t>Re-CoQ9</t> ( g ) control and ( h ) Re-CoQ10-treated mouse and Ox-CoQ9 ( i ) control and ( j ) Re-CoQ10-treated mouse. The obtained image data is presented using a rainbow scale and normalized versus total ion count (right bar chart); scale bars, 500 μm. Olfactory tuberculum, OT; caudate-putamen, CP; corpus callosum, CC; parietal association cortex, PAC; midbrain, MB; thalamus, TH; hippocampus, HIPP; hypothalamus; HY, substantia nigra, SN; ventral striatum, STRv; brain stem (BS), cerebral cortex (CTX).
Ox Coq9, supplied by Kaneka Corp, used in various techniques. Bioz Stars score: 75/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ox coq9/product/Kaneka Corp
Average 75 stars, based on 12 article reviews
Price from $9.99 to $1999.99
ox coq9 - by Bioz Stars, 2020-01
75/100 stars

Images

1) Product Images from "Imaging mass spectrometry analysis of ubiquinol localization in the mouse brain following short-term administration"

Article Title: Imaging mass spectrometry analysis of ubiquinol localization in the mouse brain following short-term administration

Journal: Scientific Reports

doi: 10.1038/s41598-017-13257-8

Imaging mass spectrometry (IMS) of CoQs. Optical image of a sagittal tissue section from the mouse brain ( a ) control and ( b ) Re-CoQ10-treated mouse). MS spectra reconstructed image of Re-CoQ10 ( c ) control and ( d ) Re-CoQ10-treated mouse, Ox-CoQ10 ( e ) control and ( f ) Re-CoQ10-treated mouse Re-CoQ9 ( g ) control and ( h ) Re-CoQ10-treated mouse and Ox-CoQ9 ( i ) control and ( j ) Re-CoQ10-treated mouse. The obtained image data is presented using a rainbow scale and normalized versus total ion count (right bar chart); scale bars, 500 μm. Olfactory tuberculum, OT; caudate-putamen, CP; corpus callosum, CC; parietal association cortex, PAC; midbrain, MB; thalamus, TH; hippocampus, HIPP; hypothalamus; HY, substantia nigra, SN; ventral striatum, STRv; brain stem (BS), cerebral cortex (CTX).
Figure Legend Snippet: Imaging mass spectrometry (IMS) of CoQs. Optical image of a sagittal tissue section from the mouse brain ( a ) control and ( b ) Re-CoQ10-treated mouse). MS spectra reconstructed image of Re-CoQ10 ( c ) control and ( d ) Re-CoQ10-treated mouse, Ox-CoQ10 ( e ) control and ( f ) Re-CoQ10-treated mouse Re-CoQ9 ( g ) control and ( h ) Re-CoQ10-treated mouse and Ox-CoQ9 ( i ) control and ( j ) Re-CoQ10-treated mouse. The obtained image data is presented using a rainbow scale and normalized versus total ion count (right bar chart); scale bars, 500 μm. Olfactory tuberculum, OT; caudate-putamen, CP; corpus callosum, CC; parietal association cortex, PAC; midbrain, MB; thalamus, TH; hippocampus, HIPP; hypothalamus; HY, substantia nigra, SN; ventral striatum, STRv; brain stem (BS), cerebral cortex (CTX).

Techniques Used: Imaging, Mass Spectrometry

Chemical structures of ubiquinol ( a ) and the oxidized form of coenzyme Q10 (n = 10) and coenzyme Q9 (n = 9) ( b ).
Figure Legend Snippet: Chemical structures of ubiquinol ( a ) and the oxidized form of coenzyme Q10 (n = 10) and coenzyme Q9 (n = 9) ( b ).

Techniques Used:

2) Product Images from "Imaging mass spectrometry analysis of ubiquinol localization in the mouse brain following short-term administration"

Article Title: Imaging mass spectrometry analysis of ubiquinol localization in the mouse brain following short-term administration

Journal: Scientific Reports

doi: 10.1038/s41598-017-13257-8

Imaging mass spectrometry (IMS) of CoQs. Optical image of a sagittal tissue section from the mouse brain ( a ) control and ( b ) Re-CoQ10-treated mouse). MS spectra reconstructed image of Re-CoQ10 ( c ) control and ( d ) Re-CoQ10-treated mouse, Ox-CoQ10 ( e ) control and ( f ) Re-CoQ10-treated mouse Re-CoQ9 ( g ) control and ( h ) Re-CoQ10-treated mouse and Ox-CoQ9 ( i ) control and ( j ) Re-CoQ10-treated mouse. The obtained image data is presented using a rainbow scale and normalized versus total ion count (right bar chart); scale bars, 500 μm. Olfactory tuberculum, OT; caudate-putamen, CP; corpus callosum, CC; parietal association cortex, PAC; midbrain, MB; thalamus, TH; hippocampus, HIPP; hypothalamus; HY, substantia nigra, SN; ventral striatum, STRv; brain stem (BS), cerebral cortex (CTX).
Figure Legend Snippet: Imaging mass spectrometry (IMS) of CoQs. Optical image of a sagittal tissue section from the mouse brain ( a ) control and ( b ) Re-CoQ10-treated mouse). MS spectra reconstructed image of Re-CoQ10 ( c ) control and ( d ) Re-CoQ10-treated mouse, Ox-CoQ10 ( e ) control and ( f ) Re-CoQ10-treated mouse Re-CoQ9 ( g ) control and ( h ) Re-CoQ10-treated mouse and Ox-CoQ9 ( i ) control and ( j ) Re-CoQ10-treated mouse. The obtained image data is presented using a rainbow scale and normalized versus total ion count (right bar chart); scale bars, 500 μm. Olfactory tuberculum, OT; caudate-putamen, CP; corpus callosum, CC; parietal association cortex, PAC; midbrain, MB; thalamus, TH; hippocampus, HIPP; hypothalamus; HY, substantia nigra, SN; ventral striatum, STRv; brain stem (BS), cerebral cortex (CTX).

Techniques Used: Imaging, Mass Spectrometry

Chemical structures of ubiquinol ( a ) and the oxidized form of coenzyme Q10 (n = 10) and coenzyme Q9 (n = 9) ( b ).
Figure Legend Snippet: Chemical structures of ubiquinol ( a ) and the oxidized form of coenzyme Q10 (n = 10) and coenzyme Q9 (n = 9) ( b ).

Techniques Used:

Related Articles

High Performance Liquid Chromatography:

Article Title: Imaging mass spectrometry analysis of ubiquinol localization in the mouse brain following short-term administration
Article Snippet: Chemicals Re-CoQ10, Ox-CoQ10, Re-CoQ9 and Ox-CoQ9 were obtained from Kaneka Corporation (Osaka, Japan). .. All reagents were high-performance liquid chromatography (HPLC) grade.

Flow Cytometry:

Article Title: Right Ventricular Myocardial Infarction due to Right Coronary Artery Total Occlusion Originating From the Distal Left Circumflex Artery
Article Snippet: Immediately after thrombus aspiration with a thrombus aspiration catheter (Thrombuster II®, Kaneka, Osaka, Japan) at the distal LCX, percutaneous coronary intervention (PCI) was followed by balloon angioplasty (Ikazuchi® 3.0×15 mm, Kaneka, Osaka, Japan) and stent insertion (Biomatrix® 4.0×18 mm, Biosensors, Morges, Switzerland) at the distal LCX. .. After stent insertion, CAG showed no residual stenosis and good distal flow at the distal LCX.

Enzyme Immunoassay:

Article Title: Endovascular Therapy for Fibromuscular Dysplasia of the Bilateral External Iliac Arteries Visualized with Optical Coherence Tomography
Article Snippet: There were 40–50 mmHg pressure gradients in the bilateral EIAs lesions. .. We performed balloon angioplasty using a 6.0×80 mm balloon [Jackal RX 6.0×80 mm (Kaneka Corporation, Osaka, Japan)].

Coagulation:

Article Title: The combined use of an aspiration catheter and balloon angioplasty for acute atherosclerotic occlusion of the middle cerebral artery
Article Snippet: Heparin was injected and the activated coagulation time was controlled at 250 seconds. .. The CHIKAI extension wire (Asahi Intec) was then connected to the end of the microguidewire, the microcatheter was removed, and the balloon catheter (Unryu 2.0–10 mm, Kaneka Medix, Osaka, Japan) was navigated to the occluded lesion and dilated to 6 standard atmosphere (atm) ( ).

Imaging:

Article Title: Endovascular Therapy for Fibromuscular Dysplasia of the Bilateral External Iliac Arteries Visualized with Optical Coherence Tomography
Article Snippet: Furthermore, OCT images (C7 XR OCT Intravascular Imaging System, St. Jude Medical, Minnesota, USA) clearly showed thickening and thinning of the middle layer , while three-dimensional OCT images showed a ‘haustra coli’-like appearance ( ). .. We performed balloon angioplasty using a 6.0×80 mm balloon [Jackal RX 6.0×80 mm (Kaneka Corporation, Osaka, Japan)].

Computed Tomography:

Article Title: Protrusion of a loop‐shaped 0.035‐inch wire without the fracture of the self‐expanding nitinol stent: A case report and experimental study. Protrusion of a loop‐shaped 0.035‐inch wire without the fracture of the self‐expanding nitinol stent: A case report and experimental study
Article Snippet: The ankle‐brachial index was 0.81 on the right and 0.45 on the left, and contrast computed tomography and angiography revealed occlusion of the left SFA. .. Balloon angioplasty with a 3.0 × 20‐mm balloon catheter (Shiden; Kaneka Medix Corporation, Tokyo, Japan) was performed because a few centimeters of the 0.014‐inch wire were located within the stent, which was confirmed by rotation angiography.

Article Title: Right Ventricular Myocardial Infarction due to Right Coronary Artery Total Occlusion Originating From the Distal Left Circumflex Artery
Article Snippet: Immediately after thrombus aspiration with a thrombus aspiration catheter (Thrombuster II®, Kaneka, Osaka, Japan) at the distal LCX, percutaneous coronary intervention (PCI) was followed by balloon angioplasty (Ikazuchi® 3.0×15 mm, Kaneka, Osaka, Japan) and stent insertion (Biomatrix® 4.0×18 mm, Biosensors, Morges, Switzerland) at the distal LCX. .. Before discharge, contrast enhanced 320-slice multi-detector cardiac computed tomography showed that the RCA ostium was absent , and the distal LCX was extended to the RCA territory while supplying the right ventricle and patent distal LCX stent ( ).

Injection:

Article Title: The combined use of an aspiration catheter and balloon angioplasty for acute atherosclerotic occlusion of the middle cerebral artery
Article Snippet: Heparin was injected and the activated coagulation time was controlled at 250 seconds. .. The CHIKAI extension wire (Asahi Intec) was then connected to the end of the microguidewire, the microcatheter was removed, and the balloon catheter (Unryu 2.0–10 mm, Kaneka Medix, Osaka, Japan) was navigated to the occluded lesion and dilated to 6 standard atmosphere (atm) ( ).

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    Kaneka Corp ubiquinol
    Brain MR images of patient. Upper images were obtained at 60 years of age (before supplementation of <t>ubiquinol),</t> and lower images were obtained at 63 years of age (after 36 months of ubiquinol 1200 mg/day). T1-weighted sagittal images ( left ) and T2-weightd axial images at the middle regions of the pontine base ( right ). They show gross atrophy of the infratentorial structures especially in the pons, middle cerebellar peduncle, and cerebellum
    Ubiquinol, supplied by Kaneka Corp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ubiquinol/product/Kaneka Corp
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ubiquinol - by Bioz Stars, 2020-01
    86/100 stars
      Buy from Supplier

    Image Search Results


    Brain MR images of patient. Upper images were obtained at 60 years of age (before supplementation of ubiquinol), and lower images were obtained at 63 years of age (after 36 months of ubiquinol 1200 mg/day). T1-weighted sagittal images ( left ) and T2-weightd axial images at the middle regions of the pontine base ( right ). They show gross atrophy of the infratentorial structures especially in the pons, middle cerebellar peduncle, and cerebellum

    Journal: Cerebellum (London, England)

    Article Title: Three-Year Follow-Up of High-Dose Ubiquinol Supplementation in a Case of Familial Multiple System Atrophy with Compound Heterozygous COQ2 Mutations

    doi: 10.1007/s12311-017-0846-9

    Figure Lengend Snippet: Brain MR images of patient. Upper images were obtained at 60 years of age (before supplementation of ubiquinol), and lower images were obtained at 63 years of age (after 36 months of ubiquinol 1200 mg/day). T1-weighted sagittal images ( left ) and T2-weightd axial images at the middle regions of the pontine base ( right ). They show gross atrophy of the infratentorial structures especially in the pons, middle cerebellar peduncle, and cerebellum

    Article Snippet: Ubiquinol in the powder form (Kaneka QH ubiquinol) was provided by Kaneka Corporation (Tokyo, Japan).

    Techniques:

    CMRO 2 images before and after ubiquinol supplementation at 1200 mg/day

    Journal: Cerebellum (London, England)

    Article Title: Three-Year Follow-Up of High-Dose Ubiquinol Supplementation in a Case of Familial Multiple System Atrophy with Compound Heterozygous COQ2 Mutations

    doi: 10.1007/s12311-017-0846-9

    Figure Lengend Snippet: CMRO 2 images before and after ubiquinol supplementation at 1200 mg/day

    Article Snippet: Ubiquinol in the powder form (Kaneka QH ubiquinol) was provided by Kaneka Corporation (Tokyo, Japan).

    Techniques:

    CBF images before and after ubiquinol supplementation at 1200 mg/day

    Journal: Cerebellum (London, England)

    Article Title: Three-Year Follow-Up of High-Dose Ubiquinol Supplementation in a Case of Familial Multiple System Atrophy with Compound Heterozygous COQ2 Mutations

    doi: 10.1007/s12311-017-0846-9

    Figure Lengend Snippet: CBF images before and after ubiquinol supplementation at 1200 mg/day

    Article Snippet: Ubiquinol in the powder form (Kaneka QH ubiquinol) was provided by Kaneka Corporation (Tokyo, Japan).

    Techniques:

    Summary of clinical course with ubiquinol supplementation. After the baseline assessment, the patient was started on ubiquinol at 600 mg/day (given once a day), with the dose increased to 840 mg/day at week 2 and to 1200 mg/day at week 6. The 1200-mg/day dose was maintained until week 8. After an interval of 8 weeks, the patient resumed taking ubiquinol at 1200 mg/day. To date, he remains taking ubiquinol at this same dose for over 3 years. BW body weight, sCre serum creatinine level

    Journal: Cerebellum (London, England)

    Article Title: Three-Year Follow-Up of High-Dose Ubiquinol Supplementation in a Case of Familial Multiple System Atrophy with Compound Heterozygous COQ2 Mutations

    doi: 10.1007/s12311-017-0846-9

    Figure Lengend Snippet: Summary of clinical course with ubiquinol supplementation. After the baseline assessment, the patient was started on ubiquinol at 600 mg/day (given once a day), with the dose increased to 840 mg/day at week 2 and to 1200 mg/day at week 6. The 1200-mg/day dose was maintained until week 8. After an interval of 8 weeks, the patient resumed taking ubiquinol at 1200 mg/day. To date, he remains taking ubiquinol at this same dose for over 3 years. BW body weight, sCre serum creatinine level

    Article Snippet: Ubiquinol in the powder form (Kaneka QH ubiquinol) was provided by Kaneka Corporation (Tokyo, Japan).

    Techniques: